Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy

PR Newswire - Press Release

All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here

U.S. now open for enrollment of rare, rapidly progressive Parkinsonian Disorder

MELBOURNE, Australia and SAN FRANCISCO, Jan. 9, 2023 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the Company's Phase 2 clinical trial of ATH434 for the treatment of patients with Multiple System Atrophy (MSA) is now open for enrollment at Vanderbilt University Medical Center in Nashville, Tennessee.

Read more at prnewswire.com

Related Symbols

Symbol Last Chg %Chg
ATHE 3.01 -0.28 -8.51%
Alterity Therapeutics Ltd ADR

Most Popular News

Stacked silver bars by Tookapic via Pixabay 1
After a Record-Setting Run, This Signal Says Silver Prices Might Be Peaking. Here’s How to Play It.
Nvidia logo by Konstantin Savusia via Shutterstock 2
The Saturday Spread: Here’s How to Properly Trade the Nvidia (NVDA) Stock Discount
Broadcom Inc logo on building-by Poetra_ RH via Shutterstock 3
Broadcom Stock Dips Post Earnings: Is AVGO a Buy, Sell, or Hold?
Magnifying glass showing the words Pre Market by Evan_huang via Shutterstock 4
Inflation Data, AI Earnings and Other Can't Miss Items this Week
Alphabet (Google) Image by Markus Mainka via Shutterstock 5
How to Make a 1.77% 1-Month Yield in GOOGL Stock - It Still Looks Undervalued
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot